NCT06577701 - Respiratory Disease Cohort Studies of Chinese Medicine for COPD(RESEARCH-COPD) | Biotech Hunter

Enrollment

10,000

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

October 30, 2027

Conditions

Chronic Obstructive Pulmoriary Disease (COPD)Preserved Ratio Impaired Spirometry (PRISM)

Interventions

DRUG

traditional Chinese medicine (TCM)

Regulated use of Chinese medicine treatment protocols is included as an exposure factor. Exposure was defined as taking the medication continuously for more than 3 months per year, or taking the medication intermittently for more than 6 months per year. According to the standardised use of TCM protocols, the group was divided into an exposed group (TCM protocols cohort) and a non-exposed group (non-TCM protocols cohort).

DRUG

non traditional Chinese medicine (non-TCM)

Regulated use of Chinese medicine treatment protocols is included as an exposure factor. Exposure was defined as taking the medication continuously for more than 3 months per year, or taking the medication intermittently for more than 6 months per year. According to the standardised use of TCM protocols, the group was divided into an exposed group (TCM protocols cohort) and a non-exposed group (non-TCM protocols cohort).

Trial Locations (1)

Unknown

The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou